This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Speech and Language Therapy After Stroke

This study has been terminated.
(Protocol expired; PI retired)
Sponsor:
Collaborators:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Shirley Ryan AbilityLab
Information provided by (Responsible Party):
University of Chicago
ClinicalTrials.gov Identifier:
NCT00713050
First received: July 9, 2008
Last updated: June 10, 2013
Last verified: June 2013
  Purpose
Our overall goal is to advance the state of functional brain imaging in aphasia, and then to apply the method to an intensive, imitation-based treatment for non-fluent aphasia.

Condition Intervention
Ischemic Stroke Behavioral: Imitate Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Neurophysiological Measurement in Aphasia Treatment

Resource links provided by NLM:


Further study details as provided by University of Chicago:

Primary Outcome Measures:
  • Changes in scores on Western Aphasia Battery [ Time Frame: Four months ]

Enrollment: 34
Study Start Date: August 2007
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Experimental
Computer-based Aphasia therapy
Behavioral: Imitate Therapy
Imitation-based computer therapy
Other Name: Imitate
Active Comparator: Control
Control Arm - Healthy subjects.
Behavioral: Imitate Therapy
Imitation-based computer therapy
Other Name: Imitate

Detailed Description:
Detailed information will follow in the next progress report.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Single ischemic infarction in the MCA territory involving the cerebral cortex (confirmed by CT or MRI)
  2. Aphasia
  3. Visual attention and language comprehension sufficient to perform imitation fMRI tasks
  4. Right handed (prior to stroke)

Exclusion Criteria:

Exclusions to the study are people with cardiac pacemakers, claustrophobia, neurosurgical clips, or cognitive impairments too severe to permit cooperation with cognitive tasks in an MRI scanner.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00713050

Locations
United States, California
Solodkin/Small Brain Circuits Laboratory
Irvine, California, United States, 92697
University of California Irvine
Irvine, California, United States, 92697
Sponsors and Collaborators
University of Chicago
National Institute on Deafness and Other Communication Disorders (NIDCD)
Shirley Ryan AbilityLab
Investigators
Principal Investigator: Steven Small, M.D., Ph.D. University of Chicago
  More Information

Responsible Party: University of Chicago
ClinicalTrials.gov Identifier: NCT00713050     History of Changes
Other Study ID Numbers: 13785A
5R01DC007488-05 ( U.S. NIH Grant/Contract )
Study First Received: July 9, 2008
Last Updated: June 10, 2013

Keywords provided by University of Chicago:
stroke
aphasia
imitation
mirror neuron

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 19, 2017